1,875
Views
22
CrossRef citations to date
0
Altmetric
Editorial

Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis

, &
Pages 801-804 | Published online: 29 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Pedro Santos-Moreno, Gabriel-Santiago Rodríguez-Vargas, Susan Martínez, Linda Ibatá & Adriana Rojas-Villarraga. (2022) Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications. Open Access Rheumatology: Research and Reviews 14, pages 255-267.
Read now
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti & Francesco Puppo. (2019) Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 18:3, pages 219-229.
Read now
Giuseppe Murdaca, Simone Negrini, Ottavia Magnani, Elena Penza, Marco Pellecchio, Rossella Gulli, Paola Mandich & Francesco Puppo. (2018) Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Modern Rheumatology 28:3, pages 417-431.
Read now
Giuseppe Murdaca, Simone Negrini, Ottavia Magnani, Elena Penza, Marco Pellecchio & Francesco Puppo. (2017) Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Expert Opinion on Drug Safety 16:10, pages 1173-1179.
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo. (2016) Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?. Expert Opinion on Drug Safety 15:1, pages 43-52.
Read now
Yara Dadalti Fragoso & Joseph Bruno Bidin Brooks. (2015) Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases. Expert Review of Clinical Pharmacology 8:3, pages 315-320.
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo. (2015) Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 14:4, pages 571-582.
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy. Expert Opinion on Drug Metabolism & Toxicology 10:12, pages 1703-1710.
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety 13:5, pages 649-661.
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2014) Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. Expert Opinion on Drug Safety 13:3, pages 295-305.
Read now

Articles from other publishers (11)

Xiaogang Zhang, Mingming Zhang, Zhiqiang Wang, Yanqing Liu, Xing Feng, Liu Yang, Yajing Wang, Juan Liu & Dongbao Zhao. (2022) Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis. Medicine 101:49, pages e32154.
Crossref
Muhammad Torequl Islam, Cristina Quispe, Jesús Herrera-Bravo, Md. Mizanur Rahaman, Rajib Hossain, Chandan Sarkar, Md Abdur Raihan, Md. Mashrur Chowdhury, Shaikh Jamal Uddin, Jamil A. Shilpi, João Marcelo de Castro e Sousa, Ana Amélia de Carvalho Melo-Cavalcante, Mohammad S. Mubarak, Javad Sharifi-Rad & Daniela Calina. (2022) Activities and Molecular Mechanisms of Diterpenes, Diterpenoids, and Their Derivatives in Rheumatoid Arthritis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-20.
Crossref
Ekta Singh, Riyaz Ali M. Osmani, Rinti Banerjee, Amr Selim Abu Lila, Afrasim Moin, Khaled Almansour, Hany H. Arab, Hadil Faris Alotaibi & El-Sayed Khafagy. (2022) Poly ε-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model. Pharmaceutics 14:3, pages 519.
Crossref
Xueni Wang, Gang Fang, Yang Yang & Yuzhou Pang. (2019) The newly discovered natural compounds against rheumatoid arthritis-an overview. Phytochemistry Letters 34, pages 50-58.
Crossref
Javaid Alam, Ibrahim Jantan & Syed Nasir Abbas Bukhari. (2017) Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy. Biomedicine & Pharmacotherapy 92, pages 615-633.
Crossref
Qi Xu, Yong Zhou, Rong Zhang, Zhan Sun & Lu-feng Cheng. (2017) Antiarthritic Activity of Qi-Wu Rheumatism Granule (a Chinese Herbal Compound) on Complete Freund’s Adjuvant-Induced Arthritis in Rats. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-13.
Crossref
Bo Nie, Xue Li, Yi Wei, Meng Chen, Jingwei Zhou, Lixia Lou, Bin Dong, Aiming Wu, Dongmei Zhang, Lingqun Zhu, Jiuli Zhao & Limin Chai. (2016) Xianfanghuomingyin, a Chinese Compound Medicine, Modulates the Proliferation and Differentiation of T Lymphocyte in a Collagen-Induced Arthritis Mouse Model. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-14.
Crossref
Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, Paola Mandich & Francesco Puppo. (2014) Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept?. Drug Development Research 75, pages S7-S10.
Crossref
Monika Østensen. (2014) Safety issues of biologics in pregnant patients with rheumatic diseases. Annals of the New York Academy of Sciences 1317:1, pages 32-38.
Crossref
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla & Francesco Puppo. (2014) Potential use of TNF-α inhibitors in systemic sclerosis. Immunotherapy 6:3, pages 283-289.
Crossref
Perle Totoson, Katy Maguin-Gaté, Clément Prati, Daniel Wendling & Céline Demougeot. (2014) Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Research & Therapy 16:1, pages R22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.